In patients with RA, implanted VNS devices activated the inflammatory reflex, leading to marked reductions in TNF, IL‐1β, and IL‐6 in response to endotoxin challenge, which correlated with clinical improvement [61, 599]. The gene discussed is TNF; the disease is rheumatoid arthritis.